March 19, 2021

Editorial

This issue of OR Manager is being published just about a year after the nationwide shutdown that was implemented to curb the spread of SARS-CoV-2, the virus that causes COVID-19. Failures on many fronts ensued in the months that followed, with an excessive death toll and unprecedented disruptions in every aspect of life throughout 2020. At the same time, amazing progress was made in the development of new vaccines, two of which the US Food and Drug Administration approved under Emergency Use Authorization (EUA) by year end. EUA of a third vaccine followed in February 2021.

Welcome to OR Manager, your source of information and insight into the clinical and business management of the surgical suite. This article is only available to OR Manager subscribers. To read this article, and gain access to all OR Manager resources, please log in below:

LOGIN

Not a subscriber? That’s OK, subscribe today! OR Manager offers all-access subscriptions at an affordable rate. With your subscription – or your team’s group subscription – you’ll receive access to all that OR Manager has to offer, including our monthly issues, CE credit opportunities, job postings, and discounts to our industry-leading conferences.

Explore Subscription Options

Please contact our Customer Service Team if you are unable to log in at [email protected] or 1-888-707-5814.

Get OR Manager Updates

Sign Up Now
Latest Issue of OR Manager
June 2023
Video Spotlight
Live chat by BoldChat